Key result
Ticagrelor reduces shear-induced platelet activation in bovine blood, especially when given after shear exposure.
Why the study?
Blood pumps generate non-physiological shear stress (NPSS) that activates platelets and disrupts haemostasis, yet the effects of ticagrelor under NPSS remain unclear.
Does ticagrelor mitigate shear-induced platelet activation in bovine blood exposed to non-physiological shear stress?
Population
Citrated bovine blood circulated in a Rotaflow loop
Comparison
Ticagrelor before circulation vs after shear stress exposure vs varying shear stress levels
Design
In vitro experimental study
Follow-up
Up to 3 h
Authors
Loading...
May warrant ticagrelor timing optimization in MCS; leaves open clinical benefit pending human trials.
Does ticagrelor mitigate shear-induced platelet activation in bovine blood exposed to non-physiological shear stress?
In an in vitro blood pump model, ticagrelor effectively reduced shear-induced platelet activation, particularly when administered after shear exposure, suggesting timing of antiplatelet therapy may optimize haemostasis in mechanical circulatory support.
Wang et al. (2026) studied Platelet activation under non-physiological shear stress. Ticagrelor vs. Administration before circulation vs after shear stress exposure was evaluated on Platelet activation, P2Y12 receptor surface expression, adhesion, aggregation, and clot kinetics. Ticagrelor reduced shear-induced platelet activation in bovine blood, with the greatest reduction occurring when administered after shear exposure.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: